Cargando…
Fluconazole in the treatment of Cushing's disease
Ketoconazole was a first-line agent for suppressing steroidogenesis in Cushing's disease. It now has limited availability. Fluconazole, another azole antifungal, is an alternative, although its in vivo efficacy is unclear. A 61-year-old female presented with weight gain, abdominal striae and wo...
Autores principales: | Burns, Kharis, Christie-David, Darshika, Gunton, Jenny E |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bioscientifica Ltd
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4744941/ https://www.ncbi.nlm.nih.gov/pubmed/26858837 http://dx.doi.org/10.1530/EDM-15-0115 |
Ejemplares similares
-
Fluconazole treatment in severe ectopic Cushing syndrome
por: Canteros, Teresa M, et al.
Publicado: (2019) -
Fluconazole and acetazolamide in the treatment of ectopic Cushing's syndrome with severe metabolic alkalosis
por: Schwetz, Verena, et al.
Publicado: (2015) -
Osilodrostat in Cushing’s disease: the management of its efficacy and the pitfalls of post-surgical results
por: Antonini, Simone, et al.
Publicado: (2022) -
Cushing’s disease: Does low-dose pasireotide offer a comparable efficacy and safety to high-dose?
por: Wong, Mimi, et al.
Publicado: (2021) -
Severe Cushing’s syndrome from an ectopic adrenocorticotropic hormone-secreting neuroendocrine tumour treated by osilodrostat
por: Hána, Václav, et al.
Publicado: (2023)